New immunisation resource for children

The Mexican Virology Network was founded in 2015 with the aims of promoting research into virus detection and treatment. To reflect their keen interest in communicating facts about diseases and prevention, they have created a new children's book outlining the importance of vaccination. "Paul has Measles" hopes to teach children, their parents and their teachers how important it is to prevent infectious diseases. It has been translated into many languages in an effort to reach the broader population. To view the English version, please click on the link below

Paul Has Measles


Influenza vaccine for Aboriginal and Torres Strait Islander people

The November meeting of the PBAC saw a positive endorsement for the extension of the influenza vaccine program for Aboriginal and Torres Strait Islander people aged 5 -17 years. This decision supports influenza vaccine funding for Aboriginal and Torres Straight Islander people of all ages on the NIP.

Please refer to the link below for further information:

November 2018 PBAC meeting positive recommendations


New vaccine preventable disease fact sheets

The Australian Institute of Health and Welfare (AIHW) has developed a series of factsheets detailing various vaccine preventable diseases (VPD's). These fact sheets provide information regarding the diseases, the number of cases reported in Australia, as well as rates of hospitalisation and deaths.

The fact sheets can be found via the following link:

AIHW fact sheets

 

 


Updated SAEFVIC Reporting Form (Online/ Print)

In support of the environment and sustainability efforts, MVEC encourages online reporting of adverse events following immunisations on www.aefican.org.au; online reporting ensures accuracy of information submitted to SAEFVIC. 
However if a print copy is preferred, an updated SAEFVIC reporting form is now available on the 赛维克 页。


WHO Immunization Monitoring Academy Webinars

The World Health Organization (WHO) is currently hosting a series of webinars exploring specific topics in immunisation monitoring. These webinars are open to anyone with an interest in this area. Further information and details on registration can be found via the link below:

Immunization Monitoring Academy: Webinars


New meningococcal resources

澳大利亚科学院 has released a new video detailing the devastating impact of meningococcal disease.

To access this video, as well as other meningococcal information, please follow the link below:

MVEC:脑膜炎球菌病和疫苗


Menactra® 和 Prevenar 13® 共同给药

Menactra® should not be administered on the same day as Prevenar 13®. Studies have shown that co-administration may result in a decreased immune response to some of the pneumococcal serotypes. If both vaccines are required, Prevenar 13® should be administered first followed by Menactra® at least 4 weeks later. If these vaccines are inadvertently administered on the same day, Prevenar 13® should be repeated a minimum of 8 weeks later. Menveo® and Nimenrix® may be co-administered with Prevenar 13®.

For further information please refer to The Australian Immunisation Handbook


World Health Organisation- Rabies

The World Health Organisation (WHO) has updated its position on rabies immunisation for pre- and post-exposure prophylaxis. The following position paper provides a summary on rabies disease and vaccines and concludes with the current WHO position on the use of rabies vaccines worldwide. The systematic review can also be accessed below. For further information on rabies disease please refer to MVEC's reference page.

Rabies vaccines: WHO position paper - April 2018

Pre-exposure rabies prophylaxis: a systematic review

MVEC: Rabies

 


Global Vaccine Safety

The Global Vaccine Safety Initiative was set up in 2011 by the World Health Organsiation (WHO) to ensure that all countries had strategies in place to ensure vaccine safety. The latest highlight is available via the following link and has some great information on Adverse Events Following Immunisation (AEFI) training in our region (WPRO).

Global Vaccine Safety


英联邦资助的青少年脑膜炎球菌 ACWY 疫苗

从 2019 年 4 月开始,国家免疫计划 (NIP) 将资助 15-19 岁青少年接种脑膜炎球菌 ACWY 疫苗。在 2017 年和 2018 年,维多利亚州的青少年接种了脑膜炎球菌 ACWY 疫苗 (Menactra®),作为州资助计划的学校计划的一部分。 NIP 的这一变化将确保全国的青少年能够获得疾病保护。详情请参阅以下卫生部长的公告:

国会议员 Greg Hunt 宣布:$52 百万为青少年免费提供脑膜炎球菌疫苗


关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。